Search

Your search keyword '"Smit, E"' showing total 2,339 results

Search Constraints

Start Over You searched for: Author "Smit, E" Remove constraint Author: "Smit, E"
2,339 results on '"Smit, E"'

Search Results

1. The ULS23 Challenge: a Baseline Model and Benchmark Dataset for 3D Universal Lesion Segmentation in Computed Tomography

2. The PCQ-Infertility Revised: A New Digital Instrument to Measure Treatment Satisfaction of Fertility Patients

5. Tumoren van de long, mediastinum en pleura

7. Synthetic Pyrethroids and Water Quality

8. Synthetic Pyrethroids and Water Quality

9. Handreiking beoordeling PFAS in oppervlaktewater: consumptie van vis en andere waterdieren : kennisnotitie

10. Handreiking beoordeling PFAS in irrigatiewater : kennisnotitie

11. Handreiking beoordeling PFAS in zwemwater : kennisnotitie

12. Handreiking beoordeling PFAS in zwemwater

13. Handreiking beoordeling PFAS in irrigatiewater

14. Handreiking beoordeling PFAS in oppervlaktewater: consumptie van vis en andere waterdieren

15. PFAS verontreinigingen: een overzicht van beschikbare risicobeoordelingsinstrumenten voor gebruiksfuncties van oppervlaktewater

16. Trends in mortality in people with HIV from 1999 to 2020: a multi-cohort collaboration

17. Arsenic exposure and the seroprevalence of total hepatitis A antibodies in the US population: NHANES, 2003–2012

21. P1.28-09 Definition of Resectable Stage III Non-small Cell Lung Cancer (NSCLC): A Clinical Case Review by a Pan-European Expert Panel

22. P2.17-06 Efficacy of Platinum after Lurbinectedin + DOX or Topotecan/CAV in Sensitive Relapsed SCLC Patients in the ATLANTIS Trial

26. Tumoren van de long, mediastinum en pleura

27. The Drug Rediscovery protocol facilitates the expanded use of existing anticancer drugs

29. Risk for non-AIDS-defining and AIDS-defining cancer of early versus delayed initiation of antiretroviral therapy

30. Contributors

32. HERTHENA-Lung01, a Phase II Trial of Patritumab Deruxtecan (HER3-DXd) in Epidermal Growth Factor Receptor-Mutated Non-Small-Cell Lung Cancer After Epidermal Growth Factor Receptor Tyrosine Kinase Inhibitor Therapy and Platinum-Based Chemotherapy

34. Werkwijze toetsing PFAS in drinkwatermonsters

35. Duiding van PFAS in Forepark en Tedingerbroekpolder – vervolgadvies voor HH Delfland

36. Aandachtvragende stoffen in rwzi-effluent: de huidige stand van de kennis

37. Factors associated with long-term antibody response after COVID-19 vaccination in patients treated with systemic treatment for solid tumors

38. Juridische en ethische aspecten van uitbreiding van de Nationale Rioolwatersurveillance

39. Trastuzumab-Emtansine and Osimertinib Combination Therapy to Target HER2 Bypass Track Resistance in EGFR Mutation-Positive NSCLC

40. Do participants in a physical activity program from a Care Sport Connector become healthier? An explorative study from the Netherlands

41. Barriers and facilitators for implementation of the SWORD evidence-based psychological intervention for fear of cancer recurrence in three different healthcare settings.

42. Oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

43. Non-oncogene-addicted metastatic non-small-cell lung cancer: ESMO Clinical Practice Guideline for diagnosis, treatment and follow-up

50. One-year data on immunogenicity and breakthrough infections in patients with solid tumors vaccinated against COVID-19 during systemic cancer treatment

Catalog

Books, media, physical & digital resources